← Open Payments lookup

DIANE GONZALES: Open Payments

NPI 1992848774 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,158 in 70 payments from 10 companies in 2025. Trend: 2023 $730 · 2024 $733 · 2025 $1,158

Food & beverage: $1,158
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.18$332
Alkermes, Inc.11$175
Teva Pharmaceuticals USA, Inc.13$156
Axsome Therapeutics, Inc.7$118
E.R. Squibb & Sons, L.L.C.5$99
ABBVIE INC.5$90
Otsuka America Pharmaceutical, Inc.3$54
Janssen Pharmaceuticals, Inc3$53
Vanda Pharmaceuticals Inc.3$49
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$33

Products named: INGREZZA, ARISTADA, UZEDY, Auvelity, COBENFY, VRAYLAR, ABILIFY ASIMTUFII, INVEGA SUSTENNA.

Industry payments across LA — which companies pay providers there.